Black Diamond Therapeutics (BDTX) Q3 2025 Earnings

7AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.37
0.08
0.53
0.98

Details

Expected EPS
-0.2475
Actual EPS
-0.19
Surprise EPS
0.06
Surprise Percent
+23.23%

Description

Black Diamond Therapeutics (BDTX) has reported earnings of -0.19 per share for Q3 2025.

0 Comments

Share your thoughts